IBM’s Quantum AI for Precision Medicine Powered by GNQ Insilico
IBM Consulting is offering a targeted personalized therapy solution, built on GNQ Insilico’s explainable, auditable causal AI (QBRM) with a multimodal Patient 360 (BioAvatar/BioLens) platform, to provide a real-time, pathway-level biological model of each individual patient to accelerate early safety signal detection, precision oncology decision support, regulator-ready evidence for DSMB/FDA workflows, and in silico trial […]